amgen glp-1 obesity drug market potential 2025 Anti-Obesity Outlook 2025–2032: Strong CAGR of 18.01% with USD 82.55 Billion Valuation GLP-1 Market Trends and Global
Description
GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide
Whether this area could expand to have single small molecules that target multiple receptors remains to be seen
Moreover, although GLP-1 has a significant effect on blood glucose control, its effect on lipid metabolism is relatively weak
While guidelines may be of value, CRNAs should have an extremely high level of suspicion and proceed conservatively in these cases until more high-quality evidence emerges
The introduction of GLP-1 agonists and SGLT-2 inhibitors offers a promising therapeutic option
